Diabetes, Vol 49, Issue 5 876-878, Copyright © 2000 by American Diabetes Association

ARTICLES

NeuroD/BETA2 gene variability and diabetes: no associations to late-onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics Group

L Hansen, JN Jensen, S Urioste, HV Petersen, F Pociot, H Eiberg, OP Kristiansen, T Hansen, P Serup, J Nerup and O Pedersen
Steno Diabetes Center, Panum Institute, University of Copenhagen, Denmark. larh@hagedorn.dk

Mutations in the NeuroD/BETA2 gene have been shown to associate with type 2 diabetes. In the present study, we examined mutations in the NeuroD/BETA2 gene for association with either type 1 or 2 diabetes. Three variants were identified in patients with type 2 diabetes: Ala45Thr (allelic frequency 0.36, 95% CI 0.31-0.41), Pro197His (0.01), and Ser259Ser (0.01). Ala45Thr and Pro197His were not associated with type 2 diabetes, but the transmission disequilibrium test showed unequal transmission of the A45 allele to offspring with type 1 diabetes (chi2 = 5.90, P < 0.02, odds ratio 1.55, 95% CI 0.91-2.63). This association could not be explained by linkage disequilibrium between the Ala45 allele and IDDM7 (D2S152), which is also located on chromosome 2q32. When tested in vitro, the biological activity of Thr45 (117+/-36% vs. Ala45) and His197 (90+/-28% vs. Pro197) on the regulation of the human insulin gene promoter appeared normal. In conclusion, mutations in the NeuroD/BETA2 gene are not a common cause of late-onset type 2 diabetes among Danes. However, in the type 1 diabetic Danish population, the Ala45Thr variant of NeuroD/BETA2 may represent a susceptibility marker independent of IDDM7 on chromosome 2q32.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Noguchi, S. Bonner-Weir, F.-Y. Wei, M. Matsushita, and S. Matsumoto BETA2/NeuroD Protein Can Be Transduced Into Cells Due to an Arginine- and Lysine-Rich Sequence Diabetes, October 1, 2005; 54(10): 2859 - 2866. [Abstract] [Full Text] [PDF]

				C. Zhang, T. Moriguchi, M. Kajihara, R. Esaki, A. Harada, H. Shimohata, H. Oishi, M. Hamada, N. Morito, K. Hasegawa, et al. MafA Is a Key Regulator of Glucose-Stimulated Insulin Secretion Mol. Cell. Biol., June 15, 2005; 25(12): 4969 - 4976. [Abstract] [Full Text] [PDF]

				K. Chu and M.-J. Tsai Neuronatin, a Downstream Target of BETA2/NeuroD1 in the Pancreas, Is Involved in Glucose-Mediated Insulin Secretion Diabetes, April 1, 2005; 54(4): 1064 - 1073. [Abstract] [Full Text] [PDF]

				A. E. Jackson, P. G. Cassell, B. V. North, S. Vijayaraghavan, S. V. Gelding, A. Ramachandran, C. Snehalatha, and G. A. Hitman Polymorphic Variations in the Neurogenic Differentiation-1, Neurogenin-3, and Hepatocyte Nuclear Factor-1{alpha} Genes Contribute to Glucose Intolerance in a South Indian Population Diabetes, August 1, 2004; 53(8): 2122 - 2125. [Abstract] [Full Text] [PDF]

				A. Vella, J. M.M. Howson, B. J. Barratt, R. C.J. Twells, H. E. Rance, S. Nutland, E. Tuomilehto-Wolf, J. Tuomilehto, D. E. Undlien, K. S. Ronningen, et al. Lack of Association of the Ala45Thr Polymorphism and Other Common Variants of the NeuroD Gene With Type 1 Diabetes Diabetes, April 1, 2004; 53(4): 1158 - 1161. [Abstract] [Full Text] [PDF]

				S. Yamada, Y. Motohashi, T. Yanagawa, T. Maruyama, A. Kasuga, H. Hirose, K. Matsubara, A. Shimada, and T. Saruta NeuroD/BETA2 Gene G->A Polymorphism May Affect Onset Pattern of Type 1 Diabetes in Japanese Diabetes Care, August 1, 2001; 24(8): 1438 - 1441. [Abstract] [Full Text] [PDF]